Microbot Medical Inc (MBOT)

[lt2211]

You are correct. The stock has been subject to manipulation since the original announcement of the reverse merger. The nature of the merger, as well as the benefit to then STEM share holders, was totally exaggerated. Phony posts claiming the new stock would soon be $20.00, were everywhere. The company had nothing to do with this, it was all outside forces. attempting to manipulate the small float. Most buyers knew little or nothing about the company. MBOT does have viable products but will need production and distribution help. A partnership looks likely down the road.